Ivabradine: a promising drug in cardiogenic shock to prevent the undesirable sinus tachycardia induced by dobutamine?

Int J Cardiol. 2015 Jan 15:178:308-10. doi: 10.1016/j.ijcard.2014.09.106. Epub 2014 Sep 28.

Authors

Benoit Lattuca¹, François Roubille²

Affiliations

¹ Cardiology Department, Montpellier University Hospital, Montpellier, France.
² Cardiology Department, Montpellier University Hospital, Montpellier, France; Inserm U1046, Montpellier, France. Electronic address: francois.roubille@gmail.com.

PMID: 25305680
DOI: 10.1016/j.ijcard.2014.09.106

No abstract available

Keywords: Cardiogenic shock; Dobutamine; Heart failure; Ivabradine.

Publication types

Editorial
Comment

MeSH terms

Benzazepines / administration & dosage*
Dobutamine / administration & dosage*
Female
Heart Failure, Systolic / diagnosis*
Heart Failure, Systolic / drug therapy*
Hemodynamics / drug effects*
Humans
Male
Severity of Illness Index*

Substances

Benzazepines
Dobutamine